| Financial Year |
March 31 2023 |
| Monetary Funds |
404,820,400.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
60,400,906.82 |
| Accounts Receivable |
844,674,854.81 |
| Advances to Suppliers |
101,655,616.68 |
| Other Receivables |
114,632,915.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
731,565,070.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
118,057,224.81 |
| Other Current Assets |
25,164,159.42 |
| Total Current Assets |
2,438,126,930.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,604,914.15 |
| Long-term Equity Investment |
25,214,138.65 |
| Investment Properties |
4,090,710.85 |
| Fixed Assetes |
702,638,555.12 |
| Under-construction Projects |
5,468,848.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
212,004,271.14 |
| R&D expenses |
-- |
| Goodwill |
690,344,521.53 |
| Long-Term Deferred and Prepaid Expenses |
51,395,901.08 |
| Deferred Income Tax Assets |
58,394,888.44 |
| Other Non-Current Assets |
14,238,479.70 |
| Sub-Total of Non-Current Assets |
1,940,853,407.05 |
| Total Assets |
4,378,980,337.46 |
| Short-Term Loans |
645,121,146.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
127,758,073.31 |
| Accounts Payable |
417,057,027.57 |
| Accounts Received In Advance |
311,755.45 |
| Employee Compensation Payable |
33,966,634.28 |
| Taxes Payable |
14,291,690.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,378,276.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
209,379,585.73 |
| Other Current Liabilities |
80,407,347.64 |
| Sub-Total of Current Liabilities |
1,546,105,812.64 |
| Long-term Loans |
140,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
65,182,998.41 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,390,202.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
260,183,391.21 |
| Total Liabilities |
1,806,289,203.85 |
| Paid-In Capital(Or Share Stock) |
464,393,929.00 |
| Capital Surplus |
1,685,436,363.56 |
| Surplus Reserve |
56,737,557.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
368,578,429.79 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,572,691,133.61 |
| Owner's Equity（Stockholder's Equity） |
2,572,691,133.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,378,980,337.46 |
